Skip to main content

Table 2 Number of prescribed anti-hypertensive compounds at baseline and at audit’s end

From: How many hypertensive patients can be controlled in “real life”: an improvement strategy in primary care

  Baseline
(mean ± SD, range)
Study’s end
(mean ± SD, range)
p
Total hypertensive population 1.17 ± 0.81 (0-7) 1.18 ± 0.82 (0-7) < 0.001
Controlled 1.25 ± 0.76 (0-7) 1.27 ± 0.76 (0-5) < 0.001
Non controlled 1.25 ± 0.87 (0-5) 1.27 ± 0.85 (0-6) < 0.001
Without final BP recording 0.88 ± 0.86 (0-6) 0.85 ± 0.88 (0-7) < 0.001